Armata Pharmaceuticals, Inc. business relationships
Companies named in Armata Pharmaceuticals, Inc.’s 10-K filed 2026-03-25, and public companies whose annual reports name Armata Pharmaceuticals, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.5 / 10
- AI naming
- <1 / 100 Top 80% in its category
- Agent readiness
- 20 / 100
- AI adoption
- 0 / 100
Named in Armata Pharmaceuticals, Inc.’s annual report 1
“Research Collaboration and Option to License Agreement, effective as of May 24, 2017, by and between Synthetic Genomics, Inc. and Merck Sharp & Dohme Corp. (incorporated herein by reference to Exhibit 10.11 to the Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2019).” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.